Biap    (DrugBank: -)

2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
46悪性関節リウマチ2
97潰瘍性大腸炎3

46. 悪性関節リウマチ [臨床試験数:4,183,薬物数:2,538(DrugBank:401),標的遺伝子数:183,標的パスウェイ数:219
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 4,183 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01416493
(ClinicalTrials.gov)
May 201111/8/2011Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid ArthritisAn OPEN LABEL Phase II Safety Study of Bovine Intestinal Alkaline Phosphatase (bIAP), an Inflammation Modulating Moiety, in RA PatientsAcute Rheumatoid ArthritisDrug: s.c. injections of bovine intestinal Alkaline PhosphataseAlloksys Life Sciences B.V.Aix ScientificsCompleted18 YearsN/ABoth6Phase 1;Phase 2United Kingdom
2EUCTR2008-007346-63-GB
(EUCTR)
05/04/201111/10/2010Reumap: An Open Label phase II study of Bovine Intestinal Alkaline Phosphatase (bIAP), An Inflammation modulating moiety, in RA patients - REUMAPReumap: An Open Label phase II study of Bovine Intestinal Alkaline Phosphatase (bIAP), An Inflammation modulating moiety, in RA patients - REUMAP Rheumatoid ArthritisProduct Name: bIAP
Product Code: EC 3.1.3.1
INN or Proposed INN: bovine intesastinal alkaline phosphatase (bIAP)
Other descriptive name: bIAP
Alloksys Life Sciences B.V.NULLNot RecruitingFemale: yes
Male: yes
Phase 2United Kingdom

97. 潰瘍性大腸炎 [臨床試験数:2,269,薬物数:1,331(DrugBank:241),標的遺伝子数:114,標的パスウェイ数:181
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
3 / 2,269 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2006-000197-69-CZ
(EUCTR)
30/05/200610/03/2006A pilot, open-label, multi-center clinical trial to investigate the safety and efficacy of Bovine-Calf Intestinal Alkaline Phosphatase in patients with moderate to severe ulcerative colitisA pilot, open-label, multi-center clinical trial to investigate the safety and efficacy of Bovine-Calf Intestinal Alkaline Phosphatase in patients with moderate to severe ulcerative colitis Inflammatory Bowel DiseaseProduct Name: Bovine-Calf Alkaline Phosphatase (BIAP)AM-Pharma B.V.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
24Czech Republic;Italy
2NCT00727324
(ClinicalTrials.gov)
May 200630/7/2008Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative ColitisA Pilot, Open-label, Multi-center Clinical Trial to Investigate the Safety and Efficacy of Bovine-Calf Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis.Ulcerative ColitisDrug: bovine intestinal alkaline phosphatase (BIAP)AM-PharmaCRM Biometrics GmbH;Sintesi Research Srl;Vigilex BVCompleted18 YearsN/ABoth22Phase 2Czech Republic;Italy
3EUCTR2006-000197-69-IT
(EUCTR)
16/03/200605/06/2006A pilot, open-label, multi-center clinical trial to investigate the safety and efficacy of Bovine-Calf Intestinal Alkaline Phosphatase in patients with moderate to severe ulcerative colitis - AP IBD 02-02A pilot, open-label, multi-center clinical trial to investigate the safety and efficacy of Bovine-Calf Intestinal Alkaline Phosphatase in patients with moderate to severe ulcerative colitis - AP IBD 02-02 Inflammatory Blowel Disease
MedDRA version: 6.1;Level: PT;Classification code 10009900
Product Name: Bovine-Calf Alkaline Phosphatase BIAP
Product Code: BIAP
AM PHARMA B.V.NULLNot RecruitingFemale: yes
Male: yes
24Italy